Victoria ImmunoPrecise Antibodies, Creates New Alliance With North

Coast Biologics To Develop Monoclonal Antibodies In Rabbits

VICTORIA / Jan 2009 /ImmunoPrecise Antibodies (IPA), of Victoria, Canada

www.Immuno-Precise.com , is pleased to announce their new alliance with North
Coast Biologics. This new partnership will allow ImmunoPrecise Antibodies to develop
monoclonal antibodies in mice and rabbits using molecular biology methods (BLAST),
enabling IPA to provide reagents for the therapeutic and diagnostic markets. BLAST
enables development of rabbit monoclonal antibodies with picomolar affinities in just
a few weeks. These BLAST mAbs can then be cloned into the constant region
framework of any species of immunoglobulin.

ImmunoPrecise Antibodies is a premier supplier of custom hybridoma antibody

development services. IPA uses proprietary and innovative inoculation (Rapid Prime)
and single-step cloning technologies (Clone-EZ) to produce mAbs significantly faster
than traditional methods of antibody production. IPA’s hybridoma development
service only requires 65 days total from start to finish. ImmunoPrecise develops
custom hybridomas in rats and mice and custom polyclonal antibodies in a variety of
species, including rabbit, goat and sheep.

In addition to ImmunoPrecise Antibodies’ custom development service,

ImmunoPrecise offers a comprehensive range of services including, epitope
prediction, custom peptide synthesis, conjugation, immunization and purification. IPA
is also capable of small-scale and bulk production of any custom antibody/hybridoma
both in vitro and as ascites.

IPA is comprised of experienced research and development scientists and

encompasses a wide range of distinctive competencies, including innovative
technologies required in the production of monoclonal and polyclonal antibodies. With
over 20 years of experience in the custom antibody business, IPA prides themselves
on providing customized, professional support.

Presently, distributors for ImmunoPrecise Antibodies are found in Australia, Canada,

and the United Kingdom. Expansion to other territories will always be considered by
simply contacting IPA. The Company boldly offers substantial discount incentives for
first time clients and academic researchers.

About The Company:

ImmunoPrecise Antibodies is a premier supplier of custom hybridoma antibody

development services. IPA uses proprietary and innovative inoculation (Rapid Prime)
and single-step cloning technologies (Clone-EZ) to produce mAbs significantly faster
than traditional methods of antibody production. For more Information on IPA visit
www.Immuno-Precise.com.

For Press Inquiries:

Dr. Jody Haddow

250.483.0308